Production of hepatitis B surface antigen in transgenic plants for oral immunization
Nature Biotechnology Nov00 v.18, n.11

Liz J. Richter¹, Yasmin Thanavala², Charles J. Arntzen¹ & Hugh S. Mason¹
 
1. Boyce Thompson Institute for Plant Research Inc., Tower Rd., Ithaca, NY 14853-1801.
2. Department of Immunology, Roswell Park Cancer Institute , Elm and Carlton Streets, Buffalo, NY 14263.
Correspondence should be addressed to H S Mason. e-mail: HSM7@cornell.edu

Here we present data showing oral immunogenicity of recombinant hepatitis B surface antigen (HBsAg) in preclinical animal trials. Mice fed transgenic HBsAg potato tubers showed a primary immune response (increases in HBsAg-specific serum antibody) that could be greatly boosted by intraperitoneal delivery of a single subimmunogenic dose of commercial HBsAg vaccine, indicating that plants expressing HBsAg in edible tissues may be a new means for oral hepatitis B immunization. However, attainment of such a goal will require higher HBsAg expression than was observed for the potatoes used in this study. We conducted a systematic analysis of factors influencing the accumulation of HBsAg in transgenic potato, including 5' and 3' flanking elements and protein targeting within plant cells. The most striking improvements resulted from (1) alternative polyadenylation signals, and (2) fusion proteins containing targeting signals designed to enhance integration or retention of HBsAg in the endoplasmic reticulum (ER) of plant cells.